Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
Holding CNTA?
Track your performance easily

Centessa Pharmaceuticals (CNTA) Financial Statements

112 Followers

Centessa Pharmaceuticals Financial Overview

Centessa Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-1.558; its P/E ratio is -10.91; Centessa Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-$ 88.00K---
Gross Profit-$ 88.00K---
EBIT$ -43.11M$ -35.04M$ -38.93M$ -48.94M$ -47.69M
EBITDA$ -42.88M$ -34.80M$ -38.70M$ -48.70M$ -47.60M
Net Income Common Stockholders$ -43.82M$ -38.05M$ -38.65M$ -24.89M$ -50.71M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 294.83M$ 230.18M$ 281.34M$ 303.59M$ 346.23M
Total Assets$ 398.85M$ 328.17M$ 377.36M$ 392.92M$ 403.86M
Total Debt$ 85.10M$ 85.54M$ 83.02M$ 82.45M$ 80.91M
Net Debt$ -209.74M$ -144.63M$ -198.32M$ -221.14M$ -265.32M
Total Liabilities$ 111.88M$ 113.01M$ 117.97M$ 116.31M$ 110.60M
Stockholders Equity$ 286.96M$ 215.16M$ 259.39M$ 276.61M$ 293.26M
Cash Flow-
Free Cash Flow$ -40.58M$ -37.29M$ -37.44M$ -44.07M$ -47.93M
Operating Cash Flow$ -40.58M$ -37.29M$ -37.39M$ -44.06M$ -47.84M
Investing Cash Flow$ -55.46M$ 16.76M$ 48.71M$ -71.10M$ -86.34M
Financing Cash Flow$ 105.31M$ 10.49M$ 14.74M$ 12.00K-
Currency in USD

Centessa Pharmaceuticals Earnings and Revenue History

Centessa Pharmaceuticals Debt to Assets

Centessa Pharmaceuticals Cash Flow

Centessa Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis